|
US5602116A
(en)
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
|
US5869473A
(en)
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US5246925A
(en)
|
1989-03-09 |
1993-09-21 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D compounds for use in treating hyperparathyroidism
|
|
CA1333616C
(en)
|
1989-03-09 |
1994-12-20 |
Hector F. Deluca |
19-nor-vitamin d compounds
|
|
AU9131091A
(en)
|
1990-11-07 |
1992-06-11 |
Scripps Research Institute, The |
Peptides that inhibit platelet binding of adhesion molecules
|
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6031003A
(en)
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
AU7634694A
(en)
|
1993-08-20 |
1995-03-21 |
University Of Medicine And Dentistry Of New Jersey |
Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same
|
|
CA2145214A1
(en)
|
1995-02-28 |
1996-08-29 |
Rick E. Preddie |
Agents for pre-symptomatic diagnosis, prevention and cure huntington's disease (hd) in humans
|
|
US5688489A
(en)
|
1995-09-15 |
1997-11-18 |
Resolution Pharmaceuticals, Inc. |
Non-receptor mediated imaging agents
|
|
US5895368A
(en)
*
|
1996-09-23 |
1999-04-20 |
Medisystems Technology Corporation |
Blood set priming method and apparatus
|
|
US6165977A
(en)
|
1996-10-18 |
2000-12-26 |
Board Of Trustees Of The Leland Stanford Junior University |
Isozyme-specific activators of protein kinase C methods and compositions
|
|
US6258774B1
(en)
|
1998-03-19 |
2001-07-10 |
University Of Medicine And Dentistry Of New Jersey |
Carrier for in vivo delivery of a therapeutic agent
|
|
JP2000336099A
(ja)
|
1999-05-27 |
2000-12-05 |
Sekisui Chem Co Ltd |
ペプチド及びｃ型肝炎抗体検出用試薬
|
|
US6274169B1
(en)
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
WO2002006218A2
(en)
|
2000-07-18 |
2002-01-24 |
Bone Care International, Inc. |
STABILIZED 1α-HYDROXY VITAMIN D
|
|
US20080249016A1
(en)
|
2000-09-18 |
2008-10-09 |
Sanos Bioscience A/S |
Use of GLP-2 in a combination treatment for bone-related disorders
|
|
US20020168354A1
(en)
|
2000-11-10 |
2002-11-14 |
Daria Mochly-Rosen |
psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
|
|
CA2434643C
(en)
|
2001-01-18 |
2013-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptides for activation and inhibition of.delta.pkc
|
|
AU2002240312A1
(en)
|
2001-02-08 |
2002-08-19 |
Pankaj Paranjp |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
|
US20030036627A1
(en)
|
2001-02-16 |
2003-02-20 |
Montelaro Ronald C. |
Virus derived antimicrobial peptides
|
|
ES2527339T3
(es)
|
2001-02-23 |
2015-01-23 |
Polyphor Ltd. |
Peptidomiméticos fijados a patrón con actividad antimicrobiana
|
|
JP2005287302A
(ja)
|
2002-04-03 |
2005-10-20 |
Haruhiko Fujiwara |
ポリペプチドの架橋方法
|
|
US20040018976A1
(en)
|
2002-05-14 |
2004-01-29 |
Feder John N. |
Polynucleotide encoding novel human G-protein coupled receptors, and splice variants thereof
|
|
WO2004093821A2
(en)
|
2003-04-22 |
2004-11-04 |
Hawaii Biotech, Inc. |
Treatment of anthrax infection using inhibitors of lethal factor protease activity
|
|
ATE377023T1
(de)
|
2003-11-05 |
2007-11-15 |
Pevion Biotech Ltd |
Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene
|
|
CA2549052A1
(en)
|
2003-12-11 |
2005-06-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Isozyme-specific antagonists of protein kinase c
|
|
US7939634B2
(en)
|
2004-01-27 |
2011-05-10 |
Compugen Ltd. |
Polynucleotides encoding polypeptides and methods using same
|
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
|
ITME20040015A1
(it)
*
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
|
AU2006285127A1
(en)
|
2005-08-30 |
2007-03-08 |
Acologix, Inc. |
Regulation of mineral and skeletal metabolism
|
|
WO2007038172A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
|
CN101668421B
(zh)
*
|
2006-11-16 |
2014-05-21 |
凯制药公司 |
用于治疗甲状旁腺功能亢进和高钙血症的聚阳离子钙调节肽
|
|
WO2008089491A2
(en)
|
2007-01-19 |
2008-07-24 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
|
WO2009046220A2
(en)
|
2007-10-02 |
2009-04-09 |
Mdrna, Inc. |
Lipopeptides for delivery of nucleic acids
|
|
EP2229473A4
(en)
|
2007-12-07 |
2011-02-02 |
Steven A Goldstein |
IDENTIFICATION OF TOXIN LIGANDS
|
|
ES2729051T3
(es)
*
|
2009-07-29 |
2019-10-30 |
Kai Pharmaceuticals Inc |
Agentes terapéuticos para reducir los niveles de hormona paratiroidea
|